Supplementary Figure 4 from Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

Alternative combination models according for the relative impact of LDH, REC, RLC and the pattern of visceral metastasis. A nomogram was developed using the nomogram function of R (A). For each patient a linear predictor score (risk score) considering the relative impact of four single factors was calculated as follows: LDH-ratio >2.5 - 100 points; presence of visceral metastasis other than lung - 96 points; REC